Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-18

Clinical Trial Update: Study on Heart Failure with Preserved Ejection Fraction with Qishen Granules [NA]

View source ↗

Summary

A clinical trial is evaluating Qishen Granules for heart failure with preserved ejection fraction and it is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Qishen Granules (Qishen Granules)

Snippet

Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine | Conditions: Heart Failure with Preserved Ejection Fraction | NA | Status: RECRUITING